NucNet Nuclear News (@nucnetnews) 's Twitter Profile Photo

🇧🇪Medical Isotopes: Belgium's #PanTera Raises €93 Million To Boost Global #Actinium-225 Production Oversubscribed A Series funding round brings total funds to €134m #Radioisotopes #Ac225 #NuclearMedicine #Belgium nucnet.org/news/pantera-r…

フラッター49|前立腺癌|好酸球性肺炎|アレルギー性気管支肺アスペルギルス症|難治性喘息 >森本雅昭 (@flutter491) 's Twitter Profile Photo

last of 3rd ③ 次の選挙にどないして当選しぃたろかっちぅて,我がのことしか考えてへん国会議員の先生なんぞになんぼ説明しぃたかて,こないなもん税金の無駄遣いなんとちゃいまんの? 元記事 innervision.co.jp/sp/report/usua… #前立腺癌 #前立腺がん #アクチニウム225 #Ac225 #常陽 x.com/flutter491/sta…

last of 3rd
③
次の選挙にどないして当選しぃたろかっちぅて,我がのことしか考えてへん国会議員の先生なんぞになんぼ説明しぃたかて,こないなもん税金の無駄遣いなんとちゃいまんの?

元記事
innervision.co.jp/sp/report/usua…
#前立腺癌
#前立腺がん
#アクチニウム225
#Ac225
#常陽
x.com/flutter491/sta…
Nusano (@nusanoinc) 's Twitter Profile Photo

Nusano to present at Jefferies Radiopharma Innovation Summit in NYC: nusano.com/nusano-to-pres… #Lu177 #Ac225 #radiopharmaceuticals #supplychain #cancer

Nusano (@nusanoinc) 's Twitter Profile Photo

Nusano to Present Isotope Production Capabilities and Commercialization Plans at 7th Theranostics World Congress. Preview presentation here: nusano.com/nusano-to-pres…… #radiopharmaceuticals #radioisotopes #cancer #Lu177 #Ac225 #At211

Nusano (@nusanoinc) 's Twitter Profile Photo

Nusano opens radiochemistry laboratory to advance isotope commercialization and customer collaboration. #Lu177 shipments expected to begin early 2025, followed by #Ac225. More: nusano.com/nusano-opens-r… #cancer #radiopharmaceuticals #API

フラッター49|前立腺癌|好酸球性肺炎|アレルギー性気管支肺アスペルギルス症|難治性喘息 >森本雅昭 (@flutter491) 's Twitter Profile Photo

last of 3rd ③ …07年の大事故破損にもめげんと再稼働を目指してやるみぃたいでんなw しやけど…「26年度の再稼働を目指す」っちぅとるぐらいやさけぇ,長ぁて厳しい道のりになりまんのでっしゃろなぁ。 元記事 yomidr.yomiuri.co.jp/article/202402… #前立腺癌 #末期がん完治 #放射線治療 #Ac225 #アクチニウム225

last of 3rd
③
…07年の大事故破損にもめげんと再稼働を目指してやるみぃたいでんなw
しやけど…「26年度の再稼働を目指す」っちぅとるぐらいやさけぇ,長ぁて厳しい道のりになりまんのでっしゃろなぁ。

元記事
yomidr.yomiuri.co.jp/article/202402…
#前立腺癌
#末期がん完治
#放射線治療
#Ac225
#アクチニウム225
フラッター49|前立腺癌|好酸球性肺炎|アレルギー性気管支肺アスペルギルス症|難治性喘息 >森本雅昭 (@flutter491) 's Twitter Profile Photo

② もんじゅ(高速増殖原型炉:核燃料サイクル施設)はんの方はトラブル続きで'16年,早々と廃炉になってもぅたんでっけど,片やこの常陽(高速増殖実験炉:ウラン資源の有効利用実験施設)はんっちぅのんは07年の大事故… 元記事 yomidr.yomiuri.co.jp/article/202402… #前立腺癌 #末期がん完治 #Ac225 #アクチニウム225

②
もんじゅ(高速増殖原型炉:核燃料サイクル施設)はんの方はトラブル続きで'16年,早々と廃炉になってもぅたんでっけど,片やこの常陽(高速増殖実験炉:ウラン資源の有効利用実験施設)はんっちぅのんは07年の大事故…

元記事
yomidr.yomiuri.co.jp/article/202402…
#前立腺癌
#末期がん完治
#Ac225
#アクチニウム225
Update in Nuclear Medicine (@update_in_nm) 's Twitter Profile Photo

Recently published article in efficacy and safety of Ac-225 PSMA therapy in mCRPC. For more details: thelancet.com/journals/lanon… #psma #psmatherapy #prostatecancer #ac225

Recently published article in efficacy and safety of Ac-225 PSMA therapy in mCRPC. For more details: thelancet.com/journals/lanon… #psma #psmatherapy #prostatecancer #ac225
NucNet Nuclear News (@nucnetnews) 's Twitter Profile Photo

🇧🇪🇺🇸#Medical isotopes: #PanTera and #TerraPower to cooperate on #Actinium-225 production Belgian and US companies to address supply gap for clinical trials #isotopes #nuclear #nuclearmedicine #ac225 #Cancer nucnet.org/news/pantera-a…

Gabriela Spilberg, MD (@gabispil) 's Twitter Profile Photo

Impressive!!! Cannot get more elegant than this!!!! If #Lu177PSMA looks like this, what about #Lead212 or #Ac225? Are we talking no surgery??? ☢️☢️☢️☢️🤔🤔🤔🤔 Bring the alphas!!!!

WisBusiness.com (@wisbusiness) 's Twitter Profile Photo

✨NorthStar Medical Radioisotopes recently announced the custom-built electron beam accelerator was delivered and installed at its #Beloit facility, which will be dedicated to producing the therapeutic #radioisotope called actinium-225 #Ac225. wisbusiness.com/2023/northstar…

✨NorthStar Medical Radioisotopes recently announced the custom-built electron beam accelerator was delivered and installed at its #Beloit facility, which will be dedicated to producing the therapeutic #radioisotope called actinium-225 #Ac225. wisbusiness.com/2023/northstar…
1stOncology (@1stoncology) 's Twitter Profile Photo

#NorthStarMedicalRadioisotopes Announces Supply Agreement with #AktisOncology for #AlphaEmitting #Therapeutic #Radioisotope #Actinium225 (#Ac225) 1stoncology.com/blog/northstar…

Ratio Therapeutics (@ratio_tx) 's Twitter Profile Photo

Ratio is focused on optimizing the delivery of #radiation to tumors while simultaneously minimizing uptake by normal tissues with its technology platform #Trillium™. Whilst its #Macropa™ chelate platform takes advantage of the tumor-killing power of the alpha emitter #Ac225.

Ratio is focused on optimizing the delivery of #radiation to tumors while simultaneously minimizing uptake by normal tissues with its technology platform #Trillium™. Whilst its #Macropa™ chelate platform takes advantage of the tumor-killing power of the alpha emitter #Ac225.